News

ABLE member Syngene International Reports FY24 Results Revenue Up 9% PAT Rises 12%

Syngene International has unveiled its full-year and fourth quarter results for the fiscal year 2024. The company reported a nine percent increase in revenue from operations for the full year, reaching Rs. 3,489 crore, accompanied by a 12 percent rise in profit after tax (PAT), before exceptional items, totaling Rs. 519 crore.

Read More

Apr 24, 2024

By : Team ABLE

BBC 8th Foundation Day Celebrated with Startup Summit

Mr Suresh, highlighted some of the highly innovative products such NexCAR19 gene therapy developed by IIT-Bombay startup, ImmunoAct and few other such success stories.

Read More

Apr 22, 2024

By : Team ABLE

We Need to be Ready for Biotech ChatGPT Moment says former Google CEO

The next big game-changing revolution is in biology.

Read More

Apr 18, 2024

By : Eric Schmidt

IIT Bombay Wins the Prestigious Praj IISER Mimamsa 2024

IIT Bombay emerged victorious at the Praj-IISER Pune 'Mimamsa 2024'

Read More

Apr 01, 2024

By : Team ABLE

G S Krishnan re-elected ABLE President for 2024 - 2026

Dr Kiran Mazumdar-Shaw, will continue as the association’s honorary non-executive chairperson.

Read More

Apr 01, 2024

By : Narayanan Suresh

 

Archives

'voice for BT' 2024

Apply Today

BEST 2024

Apply Today

Focus Areas

Highlights